Fenozolone
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(RS)-2-ethylamino-5-phenyl-1,3-oxazol-4-one
|
|
Clinical data | |
Routes of administration |
Oral |
Identifiers | |
CAS Number | 15302-16-6 Y |
ATC code | N06BA08 (WHO) |
PubChem | CID: 71682 |
ChemSpider | 64736 Y |
UNII | 1NZI4LMU6G Y |
KEGG | D07344 Y |
ChEMBL | CHEMBL2104907 |
Chemical data | |
Formula | C11H12N2O2 |
Molecular mass | 204.225 g/mol |
|
|
|
|
(verify) |
Fenozolone (Ordinator) was developed by Laboratoires Dausse in the 1960s[1] and is a psychoactive drug and stimulant related to pemoline and 4-methylaminorex which acts as a norepinephrine-dopamine releasing agent (NDRA).[2]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Stimulants
- Lactams
- Amines
- Norepinephrine-dopamine releasing agents
- Oxazolones
- Nervous system drug stubs
Hidden categories: